Research is being conducted on the alterations in chromatin architecture in cancer. Studies are exploring the mechanisms of dysregulation and potential therapeutic strategies, including the role of chromatin remodeling in restraining oncogenic functions and the impact of temporal dynamic reorganization of 3D chromatin architecture. The investigations cover various types of cancer, including prostate, breast, and potentially neurodevelopmental outcomes, as well as the activation of human T cells.